Bayer buys into Arvinas protein degrader discovery platformBayer is paying $17.5 million upfront to US biotech Arvinas, tapping into a protein-targeting platform to seek new Share XBayer buys into Arvinas protein degrader discovery platformhttps://pharmaphorum.com/news/bayer-buys-into-arvinas-protein-degrader-discovery-platform/
